Trial Profile
An Ascending Single-Dose Safety, Tolerability and Exposure Study to Explore the Maximum Tolerated Dose of GRT0151Y in Healthy Adult Non-dependent Recreational Opiate Users
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Dec 2018
Price :
$35
*
At a glance
- Drugs Axomadol (Primary)
- Indications Pain
- Focus Adverse reactions
- Sponsors Grunenthal
- 12 Dec 2018 New trial record